USFDA gives nod to Lupin generic Azilsartan Medoxomil tablets

Lupin is an innovation-led, transnational pharmaceutical company headquartered in Mumbai, India.

Picture: Pixabay

Last Updated on December 27, 2021 by The Health Master

Mumbai: Global pharma major Lupin Limited has announced that the company has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Azilsartan Medoxomil Tablets, 40 mg, and 80 mg.

The product is a generic equivalent of Edarbi Tablets, 40 mg, and 80 mg, of Arbor Pharmaceuticals, LW. This product will be manufactured at Lupin’s Nagpur facility in India.

Azilsartan Medoxomil Tablets (RLD: Edarbi Tablets) had estimated annual sales of USD 103.4 million in the U.S. (IQVIA MAT September 2021).

Lupin is an innovation-led, transnational pharmaceutical company headquartered in Mumbai, India.

The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions.

The company specializes in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and women’s health areas.

USFDA authorises first oral antiviral to treat COVID

USFDA approves expanded use of Amgen’s psoriasis drug

USFDA gives nod to Cipla for Lanreotide injection

USFDA gives Orphan Drug Designation to Zydus for malaria treatment

USFDA relaxes restriction on Abortion Pill

USFDA approved Finasteride, Tadalafil for new treatment for Benign Prostatic Hyperplasia

5 reasons why e-Rx (electronic prescription) is better than paper Rx

At-home COVID-19 rapid test gets ok from USFDA: Roche

Remdesivir drug should only be used in patients with ‘moderate to…

Schedule for 19 FDCs permitted pre-1988 to give online presentation

DCGI seeks more data from Serum Institute for Covovax Vaccine

Doctor couple booked for using restricted drug at hospital

IPC adds 15 new impurities Reference Substances and 11 IP Reference…

Drug alert: 22 out of 1102 samples declared as NSQ in…

Haryana is the best state for setting up Pharma Industries: HM

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner